The Cost-Effectiveness of Tolvaptan for the Treatment of Hyponatraemia Secondary To Syndrome Of Inappropriate Antidiuretic Hormone Secretion in Sweden

Nov 1, 2014, 00:00 AM
10.1016/j.jval.2014.08.728
https://www.valueinhealthjournal.com/article/S1098-3015(14)02658-8/fulltext
Section Title : Disease-Specific Studies
Section Order : 152
First Page : A350
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)02658-8&doi=10.1016/j.jval.2014.08.728
HEOR Topics :
Tags :
Regions :